Market Tracker

07/03 4:45pm ET

SPDR® S&P Biotech ETF (XBI)

246.94
Delayed Data
As of Jul 02
 -2.28 / -0.91%
Today’s Change
133.95
Today|||52-Week Range
261.60
+32.44%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+3.68% 3 years+39.82%
3 months+12.27% 5 years+37.67%
1 year+58.92% Since inception+19.03%
Data through 07/03/2015

Quote Details

Previous close$249.22
Open day’s range245.46 – 251.12
Net asset value (NAV)246.82 (07/02/2015)
Daily volume632,420
Average volume (3 months)1,090,825
Data as of 3:59pm ET, 07/02/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+37.67%+22.89%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.321.68
Net assets$2.3B$1.9B
Average market cap$2.4B$38.6B
Average P/E--24.7
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
PPH Market Vectors® Pharmaceutical ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 1.97%
SRPT Sarepta Therapeutics Inc1.80%
ALDR Alder Biopharmaceuticals Inc1.66%
BLUE bluebird bio Inc1.60%
DYAX Dyax Corp1.51%
RARE Ultragenyx Pharmaceutical Inc1.50%
ESPR Esperion Therapeutics Inc1.43%
PRTA Prothena Corporation PLC1.36%
MNTA Momenta Pharmaceuticals Inc1.32%
FOLD Amicus Therapeutics Inc1.32%